Oxford Lane Capital Stock (NASDAQ: OXLCN)

Latest news for Oxford Lane Capital (NASDAQ:OXLCN) Stock

Oxford Lane Capital

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

Oxford Lane Capital Corp. - 7.125% Series 2029 Term Preferred Stock

Oxford Lane Capital Corp

Shytoshi Kusama, the mysterious lead developer of the Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>), shared a GIF, purportedly celebrating the breakout rally of the ecosystem's top cryptocurrencies.
What happened:  On Thursday, the pseudonymous lead posted a meme on X, showing Vegeta, a character in the popular anime series Dragon Ball, smirking after looking at a device.
The media possibly reflected Kusama's own sentiment after watching tokens like SHIB and Bone ShibaSwap (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONE</a>) rally sharply over the day.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/hK5PDBZ91N">pic.twitter.com/hK5PDBZ91N</a>
&mdash; Shytoshi Kusama&#x2122; (@ShytoshiKusama) <a href="https://twitter.com/ShytoshiKusama/status/1839416997857083559?ref_src=twsrc%5Etfw">September 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
SHIB, the ecosystem's biggest cryptocurrency by market capitalization, soared nearly 29% in the last 24 hours, rising to levels not seen since mid-June.&nbsp;
The coin's trading volume more than tripled to $1.2 billion in the 24-hour period,&nbsp;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41053101/maxine-waters-says-crypto-is-inevitable-other-countries-are-way-ahead-of-the-united-states">Maxine Waters Says &#8216;Crypto Is Inevitable,&#8217; Other Countries Are &#8216;Way Ahead&#8217; Of The United States</a>
Additionally, BONE, the token widely used in decentralized exchange, ShibaSwap, and Layer-2 blockchain Shibarium, also bounced nearly 15%.
Why It Matters: The rally came after Shiba Inu's marketing lead, Lucie, teased details about the ecosystem's own stablecoin SHI, which was in the works.
First introduced by the project's founder, Ryoshi, in 2021, Lucie informed that SHI is a "crucial development" and its introduction was aimed at enhancing the features of Shibarium.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The SHI Stablecoin: A Key Development for Stability and Utility in the Shibarium Ecosystem The SHI stablecoin is a crucial development within the Shib ecosystem, currently in the works and not yet released. Its introduction is expected to significantly enhance the Shibarium… <a href="https://t.co/UyrJgnYR45">pic.twitter.com/UyrJgnYR45</a>
&mdash; 
</blockquote></div></figure>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BONE

$SHIB

Shiba Inu Soars 29% On SHI Stablecoin Update: Lead Developer Shytoshi Kusama Teases Breakout With Dragon Ball Meme — Burn Rate Soars 33818%

Former President Donald Trump has revealed plans to meet with Ukrainian President Volodymyr Zelenskyy in New York. This comes despite recent Republican backlash against Zelenskyy&#8217;s lobbying activities in the United States.
What Happened: Zelenskyy has been striving to appease U.S. Republicans, including Trump and House Speaker Mike Johnson (R-La.), who were upset by his outreach to Democrats. The Ukrainian president&#8217;s efforts are aimed at securing more support for Ukraine&#8217;s position against Russia, <a href="https://www.ft.com/content/401e6019-4d52-4af9-919f-c1a133badd3d">reported</a> Financial Times.
Trump announced at a New York press conference that he would meet Zelenskyy on Friday morning at Trump Tower. This follows a letter from Zelenskyy to Trump requesting a meeting to discuss Ukraine&#8217;s pursuit of a &#8220;just peace&#8221;.
Zelenskyy&#8217;s outreach to Trump comes in the wake of Republican backlash over his focus on Democratic politicians during the U.S. election campaign. This occurred despite an $8 billion aid package for Ukraine, backed by Republicans.
The GOP backlash has evoked concern in Kyiv with allies of the Ukranian President saying that his U.S. trip was not managed properly. 
&#8220;It looks like the Republicans were looking for ways to create a scandal but we should have avoided giving them the opportunity. The Republicans will still be strong in Washington. They can block everything,&#8221; said a former Ukrainian official, according to FT.
See Also: <a href="https://www.benzinga.com/markets/equities/24/09/40979752/elon-musk-says-buses-wont-be-needed-once-tesla-robotaxis-start-operating-will-take-people-point-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Says Buses Won&#8217;t Be Needed Once Tesla Robotaxis Start Operating: &#8216;Will Take People Point To Point For A Similar Cost&#8217;</a>
Why It Matters: The Friday meeting comes after a series of events that have strained relations between the two leaders. According to a previous Benzinga report Trump claimed that Zelenskyy <a href="https://www.benzinga.com/news/24/09/40998738/trump-says-ukrainian-president-backs-kamala-harris-for-white-house-zelenskyy-is-the-greatest-salesma">prefers Democrats</a> to win the upcoming 2024 U.S. election. 
On Thursday, Trump criticized Zelenskyy after a canceled meeting, accusing him of <a href="http://Trump Zelensky https://www.benzinga.com/news/24/09/41040076/trump-accuses-zelenskyy-of-making-nasty-little-dispersions-after-canceled-meeting-we-continue-to-giv">refusing to negotiate peace</a> and wasting U.S. funds. Trump claimed Zelenskyy insulted him and expressed frustration over continued U.S. financial support for Ukraine.
Zelensky&#8217;s recent U.S. visit, including a munitions factory tour in Pennsylvania, has sparked GOP outrage, with Speaker Johnson and House Oversight Chair James Comer (R-Ky.) calling it a <a href="https://www.benzinga.com/news/24/09/41037745/mike-johnson-lashes-out-over-weapons-factory-tour-snub-cries-election-interference-to-ukraine-presid">politically motivated</a> event supporting Vice President Kamala Harris. They've launched an investigation, demanding the dismissal of Ukraine&#8217;s U.S. ambassador for alleged election interference. Democrats dismissed the claims, viewing Zelensky's visit as a show of gratitude.
Image via Flickr
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

Politics

General

Trump Set To Meet Ukraine's President Amid Growing Kyiv Concerns Over Botched Visit: 'Republicans Were Looking For Ways To Create A Scandal'

Will Smith&nbsp;once had to address the allegations made by his wife,&nbsp;Jada Pinkett Smith, that he tends to ask strangers for money. The &#8220;Fresh Prince of Bel-Air&#8221; then narrated his side of the tale during a late-night talk show.
What Happened: In December 2017, Will Smith contradicted his wife&#8217;s version of an event where he supposedly asked a stranger for money. Jada had initially narrated this incident during a May 2017 appearance on &#8220;Jimmy Kimmel Live.&#8221;
Will Smith explained that the incident took place after the launch day of their company, Just Water.
&#8220;So it was the first day, and we're walking down the street in New York, and I see the first pallet coming into the Whole Foods,&#8221; he said.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/09/40998105/marques-brownlee-reviews-apples-iphone-16-and-launches-new-app-this-is-the-most-unfinished-ive-ever?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Marques Brownlee Reviews Apple&#8217;s iPhone 16 And Launches New App: &#8216;This Is The Most Unfinished I&#8217;ve Ever Seen A New iPhone Launch&#8217;</a>
However, the couple found themselves without cash to purchase their own product. At that moment, Will Smith proposed asking a passerby for a few dollars.
&#8220;[Jada said] there's no way that we're going to walk up to strangers and ask for money,&#8221; the &#8220;The Pursuit of Happyness&#8221; star recalled, adding, &#8220;And I was like, &#8216;Babe, they would like it. It would be fun for them to say Will and Jada borrowed $2.&#8217; She was like, &#8216;They aren't going to say Will and Jada did nothing.'&#8221;
&#8220;She made us walk four blocks to go and get $2 and then four blocks back to get the water, at which point it was good because I was parched,&#8221; he concluded.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Will Smith Asks Strangers for Money" width="500" height="281" src="https://www.youtube.com/embed/9mwM1VB9qs0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Why It Matters: Earlier that year, in May, when Jada appeared on the show, Kimmel recalled a story Will Smith had shared. As per the story, Will once found himself at a gas station without his wallet, low on gas, and asked a passerby for $10.
The person was shocked that Will Smith was asking for money but gave it to him nonetheless.
Jada confirmed that this wasn't an isolated incident, explaining that Will frequently pulls similar stunts, especially when she's around.
Kimmel jokingly referred to Will as "the world's most famous panhandler," to which Jada laughed and agreed.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Jada Pinkett Smith Hates When Husband Will Asks People for Money" width="500" height="281" src="https://www.youtube.com/embed/mSGt4zK75v4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Just Water was founded by Jaden Smith, with the help of his parent Will and Jada. The eco-friendly water startup was inspired by Jaden&#8217;s concern for the environment and the impact of plastic waste on the oceans.
In 2019, the company that offers responsibly sourced water from upstate New York, packaged in a bottle made from 82% renewable materials, hit a $100 million <a href="https://www.fastcompany.com/90398045/jaden-smiths-just-water-just-hit-100-million-valuation">valuation</a>.
Photo Courtesy: Shutterstock.com
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41016829/possible-but-not-probable-steve-jobs-witty-transportation-answer-in-1973-resume-earns-him-online-acc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Possible, But Not Probable&#8217;: Steve Jobs&#8217; Witty Transportation Answer In 1973 Resume Earns Him Online Accolades — Bill Gates $15k Salary No Less Impressive In The Same Era</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Entertainment

Jada Smith Once Said Will Smith Hits Up Strangers For Money, But The 'The Fresh Prince Of Bel-Air' Claims Otherwise: 'She Made Us Walk Four Blocks To Go And Get $2' Just To Buy A Bottle Of Water

Kentucky awarded the state&#8217;s first business license under its new<a href="https://www.benzinga.com/markets/cannabis/24/09/40784828/kentuckys-massive-cannabis-licensing-response-5-000-applications-filed-before-deadline"> startup program </a>on Thursday. 
KCA Labs, a hemp-testing facility based in Nicholasville, was selected to ensure that all products are tested before reaching patients, Yahoo Finance <a href="https://ca.finance.yahoo.com/news/kentucky-awards-first-business-license-200326528.html?guccounter=1">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40660012/10-years-ago-alcohol-was-banned-in-kentucky-now-theyre-voting-to-legalize-cannabis">10 Years Ago, Alcohol Was Banned In Kentucky, Now They&#8217;re Voting To Legalize Cannabis</a>
&#8220;I love that the first license is going to an entity that helps us do this safely,&#8221; Governor Andy Beshear (D) said during a press conference in Frankfort. "Our mission is to ensure Kentuckians with serious medical conditions have access to safe and high-quality, tested medical cannabis products. That's exactly what KCA is going to help us do."
<h3 class="wp-block-heading">KCA Labs Leading Safety Compliance</h3>
KCA Labs, which previously specialized in hemp testing, is now set to lead the charge in ensuring product quality for Kentucky's medical marijuana program.
CEO Jonathan Thompson expressed confidence in their readiness: "KCA's vast knowledge and experience with testing hemp products will translate neatly into Kentucky's new medical cannabis program."
Safety compliance facilities, such as KCA Labs, will play a pivotal role in testing every product to ensure they meet strict medical standards before being made available to eligible patients.
While the state will use a lottery system to grant licenses to businesses looking to grow, process or sell medical cannabis, there's no limit on the number of safety compliance licenses.
<h3 class="wp-block-heading">Licensing For Cultivators And Dispensaries</h3>
Kentucky is preparing for its next phase: awarding licenses to cultivators and processors via a lottery system scheduled for Oct. 28. A separate lottery for dispensary licenses is expected to follow in November. This method, according to Beshear, ensures a fair opportunity for applicants who successfully navigate the initial screening process.
The governor explained the reasoning behind this approach. "Caps on those licenses are meant to avoid flooding the market with products and exceeding demand." With nearly 5,000 applications submitted, the lottery system helps regulate supply, ensuring the market remains balanced and sustainable.
<h3 class="wp-block-heading">Overcoming Legislative Hurdles</h3>
Kentucky's medical marijuana program has overcome numerous legislative challenges to get to this point. After years of delays, state lawmakers passed the bill in 2023 to legalize medical cannabis for individuals with severe conditions, including cancer, multiple sclerosis, chronic pain, epilepsy, chronic nausea and post-traumatic stress disorder (PTSD).
In April of this year, Beshear signed follow-up legislation accelerating the licensing timeline by six months, allowing the program to begin awarding licenses in 2024 instead of 2025.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39828910/kentucky-gov-andy-beshear-to-dea-reschedule-cannabis-marijuana-products-will-reduce-suffering">Kentucky Gov Andy Beshear To DEA: Reschedule Cannabis &#8216;Marijuana Products Will Reduce Suffering&#8217;</a></li>
</ul>

Cannabis

Legal

Kentucky Moves Closer To Medical Cannabis Rollout With First License Awarded To Testing Lab

Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.

FDA Earlier Announced Approval Of Bristol-Myers Squibb's Cobenfy With New Mechanism Of Action For Treatment Of Schizophrenia

SEEL

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

NLS PHARMACEUTICS LTD WT PUR COM SER A EXP

NLSPW

NLSP

Offerings

STWD

Starwood Property Trust Prices Private Offering Of $400M Of Its 6.000% Unsecured Senior Notes Due 2030

WIIM

SAVA

Cassava Sciences shares are trading lower after the SEC charged the company, two former executives for misleading claims about Alzheimer's clinical trial.

SEC announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience, Lindsay Burns, will pay more than $40 million to settle charges related to misleading statements made in September 2020 about the results of a Phase 2 clinical trial for the company&rsquo;s purported therapeutic for the treatment of Alzheimer&rsquo;s disease.
Without admitting or denying the allegations, Cassava, Barbier, and Burns consented to civil injunctions against future violations and agreed to pay civil penalties of $40 million, $175,000, and $85,000, respectively. Barbier and Burns agreed to be subject to officer-and-director bars of three and five years, respectively. The settlements are subject to court approval.

SEC Charges Cassava Sciences, Two Former Executives For Misleading Claims About Alzheimer's Clinical Trial; Company To Pay Civil Penalty Of $40M

&nbsp;S&amp;P SmallCap 600 constituent SITE Centers Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SITC#NYSE">SITC</a>) is spinning off Curbline Properties in a transaction expected to be completed on October 1.
Cross Country Healthcare is no longer representative of the small-cap market space.&nbsp;

CCRN

CURBw

SITC

Curbline Properties To Be Added To S&P SmallCap 600 Effective Prior To Open Of Trading On October 1, Replacing Cross Country Healthcare

TMDX

TransMedics Group To Replace Ensign Group In S&P SmallCap 600, Effective Prior To Opening Of Trading On October 1

&nbsp;S&amp;P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.&nbsp;

ENSG

Ensign Group Set To Join S&P MidCap 400, Effective Prior To Opening Of Trading On October 1, Replacing Southwestern Energy

As cannabis consumption becomes increasingly common across the U.S., a federal advisory panel is calling for a major shift in how the government handles <a href="https://www.benzinga.com/markets/cannabis/24/09/41049042/with-70-in-favor-could-nebraskas-cannabis-program-unlock-underserved-markets-local-expert-weighs">marijuana policy. </a>
Moving away from the &#8220;Just Say No&#8221; campaigns of the past, Thursday's report from the National Academies of Sciences, Engineering and Medicine advocates for a public health-focused approach, with the Centers for Disease Control and Prevention (CDC) playing a larger role than ever before, PBS News <a href="https://www.pbs.org/newshour/health/u-s-health-authorities-need-to-play-a-larger-role-in-cannabis-policy-report-says">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/41053493/medical-marijuana-is-still-critical-balancing-act-between-recreational-medicinal-markets">&#8216;Medical Marijuana is Still Critical&#8217;: Balancing Act Between Recreational, Medicinal Markets</a>
<h3 class="wp-block-heading">A Health-Centric Shift In Cannabis Policy</h3>
"We'd like the federal government to step up to provide some leadership in this area," said Dr. Steven Teutsch of the University of Southern California, who chaired the committee behind the report. 
The CDC and the National Institutes of Health (NIH) sponsored the findings, which suggest that the rise of stronger cannabis products coupled with higher rates of daily use necessitate a more robust federal response.
A CDC spokesperson confirmed that the agency is reviewing the report&#8217;s recommendations but stressed that additional funding would be needed to implement them effectively.
<h3 class="wp-block-heading">Escalating Cannabis Potency Raises Public Health Concerns</h3>
One of the report&#8217;s key concerns is the increasing potency of marijuana. "Now you go into the stores, it's hard to find products that are less than 20% THC," noted Beau Kilmer, co-director of the RAND Drug Policy Research Center and a member of the report committee. 
This sharp increase from the roughly 5% THC levels seen 25 years ago has raised alarms over the risks associated with heavy cannabis use, including car accidents and <a href="https://www.benzinga.com/markets/cannabis/23/02/30877367/long-term-marijuana-use-can-lead-to-rare-condition-cannabinoid-hyperemesis-syndrome-say-physic-1">cannabis hyperemesis syndrome</a>, a condition that causes severe vomiting and often requires emergency medical care.
For younger users, the risks extend beyond physical health. According to the report, regular cannabis use among teenagers may interfere with learning and increase the likelihood of developing mood and anxiety disorders. Pregnant women who use cannabis regularly also risk complications for their babies.
<h3 class="wp-block-heading">Cannabis Industry Pushback</h3>
Furthermore, the report notes that cannabis industry lobbying has played a significant role in shaping state policies. In states like Washington and Colorado, efforts to limit THC concentrations or restrict the use of pesticides in cultivation have been met with resistance.
However, Aaron Smith, CEO of the National Cannabis Industry Association, defended the regulated market. "States have protected public health by replacing criminal markets with regulated businesses that are required to test products for contaminants, practice truth in labeling, and most importantly, keep cannabis products out of the hands of minors," said Smith. 
Smith added that legalizing cannabis nationally would allow for more comprehensive federal regulations, ultimately improving public health.
<h3 class="wp-block-heading">Key Recommendations From The Report</h3>
The advisory panel outlined several recommendations aimed at improving cannabis-related public health measures:
<ul>
<li>CDC: Develop and evaluate health campaigns specifically aimed at parents, teens, pregnant women, and older adults. Additionally, the agency should monitor cannabis cultivation, sales, and usage trends, while also establishing best practices for state regulations.</li>
<li>Congress: The report calls for closing a loophole that allows intoxicating hemp-derived products to be sold in states where other cannabis products remain illegal. Congress should also lift restrictions that prevent the Office of National Drug Control Policy from studying the effects of cannabis legalization.</li>
<li>States: Recommendations include requiring cannabis retail staff to undergo training and certification, expunging records for low-level cannabis-related offenses, and adopting U.S. Pharmacopeia quality standards for cannabis products.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41034042/fbi-report-over-200-000-people-were-arrested-for-cannabis-related-violations-in-2023-how-is-that">FBI Report Over 200,000 People Were Arrested For Cannabis-Related Violations In 2023: How Is That Possible?</a></li>
</ul>

Health Care

Federal Health Agencies Must Take Stronger Role In U.S. Cannabis Policy Shift, New Report Says

Management

TFPM

Triple Flag Precious Metals Appoints Sheldon Vanderkooy As CEO And Director, Succeeding Shaun Usmar Who Departs Effective On September 26, 2024

Michael Garcia, Algoma&#39;s Chief Executive Officer, stated, &quot;Our operations are performing in line with expectations for the fiscal&nbsp;second quarter, despite operating against a backdrop of challenging market conditions for steel demand and pricing.&quot;

Guidance

ASTL

Algoma Steel Expects Q2 Total Steel Shipments Of 510,000 To 520,000 Tons; Says Operations Are Performing In Line With Expectations For The Quarter

BlackBerry Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) reported second-quarter financial results Thursday after the bell. Here&#8217;s a <a href="https://www.benzinga.com/pressreleases/24/09/ac41057250/blackberry-reports-second-quarter-fiscal-year-2025-results">rundown of the report</a>.
Q2 Earnings: BlackBerry reported second-quarter revenue of $145 million, beating analyst <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $141.42 million. The company reported breakeven second-quarter earnings on an adjusted basis, beating analyst estimates for a loss of 3 cents per share, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
IoT revenue was&nbsp;$55&nbsp;million, up 12% year-over-year.&nbsp;Cybersecurity revenue totaled $87&nbsp;million in the quarter, up 10% year-over-year. Licensing revenue&nbsp;came in at $3&nbsp;million. 
BlackBerry ended the quarter with $265 million in&nbsp;cash, cash equivalents and&nbsp;short-&nbsp;and long-term investments.
&#8220;BlackBerry reached a significant milestone on our path to profitability by recording breakeven adjusted EBITDA and non-GAAP EPS. This result was achieved through a combination of stronger-than-expected, double-digit revenue growth for both IoT and Cybersecurity, as well as tremendous ongoing progress in rationalizing our cost structure. Operating expenses for the quarter were 24% lower than the baseline for the prior year,&#8221; said John Giamatteo, CEO of BlackBerry.
&#8220;QNX delivered strong royalty revenue again this quarter, and there was year-over-year revenue growth for the secure communications products in our Cybersecurity division.&#8221;
See Also: <a href="https://www.benzinga.com/news/24/09/41016947/crowdstrike-executive-struck-by-regret-in-house-hearing-says-company-determined-to-prevent-instances">CrowdStrike Executive Struck By Regret In House Hearing, Says Company Determined To Prevent Instances Like Microsoft Outage From Repeating: &#8216;Deeply Sorry This Happened&#8217;</a>
What&#8217;s Next: BlackBerry expects third-quarter revenue of $146 million to $154 million. BlackBerry sees third-quarter IoT revenue of $56 million to $60 million, cybersecurity revenue of $86 million to $90 million and licensing and other revenue of approximately $4 million. 
The company also guided for breakeven third-quarter earnings, plus or minus one cent per share.
BlackBerry anticipates full-year revenue of $591 million to $616 million. The company anticipates a full-year adjusted earnings loss of 2 cents to 5 cents per share.
Management will hold a conference call to discuss these results at 5:30 p.m. ET.
BB Price Action: <a href="https://www.benzinga.com/quote/BB" target="_blank" rel="noreferrer noopener">BlackBerry shares</a> were up 0.79% in after-hours, trading at $2.56 at the time of publication Thursday, according to <a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: Courtesy of BlackBerry.

Earnings

After-Hours Center

Movers

BlackBerry Q2 Earnings: Revenue, EPS Beat Estimates Driven By Strength In IoT, Cybersecurity

AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) has outperformed the market over the past 10 years by 1.46% on an annualized basis producing an average annual return of 12.86%. Currently, AbbVie has a market capitalization of $338.87 billion. 
Buying $1000 In ABBV: If an investor had bought $1000 of ABBV stock 10 years ago, it would be worth $3,322.37 today based on a price of $191.90 for ABBV at the time of writing.
<h3>AbbVie's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727386222_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ABBV

Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years

Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) has outperformed the market over the past 10 years by 31.24% on an annualized basis producing an average annual return of 42.65%. Currently, Fair Isaac has a market capitalization of $47.17 billion. 
Buying $100 In FICO: If an investor had bought $100 of FICO stock 10 years ago, it would be worth $3,491.49 today based on a price of $1923.81 for FICO at the time of writing.
<h3>Fair Isaac's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727386217_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FICO

$100 Invested In Fair Isaac 10 Years Ago Would Be Worth This Much Today

OXLCI: Keeping An Eye On This 8.1% Yielding Bond

Oxford Lane Capital: Locking In An 8%+ Yield With Preferred Shares

Oxford Lane Capital Corp - 7.125% PRF REDEEM 30/06/2029 declares $0.1484 dividend

Oxford Lane Capital Corporation (OXLC) Q1 2025 Earnings Call Transcript

New Preferred Stock And Exchange Traded Debt IPOs, July 2024

What To Expect From The Next Income Drawdown

The Dividends Don't Matter In Retirement, Even Big Ones

Oxford Lane Capital: Why I Think This Is A Yield Trap

Oxford Lane Capital reports August net asset value update

Gauging Distribution Winners And Losers In The Next Rate Cycle

ARCC

DCOM

DCOMG

DCOMP

FALN

FDUS

FPEI

HIGH

JBBB

MSPQL

MSTLW

MTBA

NCDL

NYMT

NYMTI

NYMTL

NYMTM

NYMTN

NYMTZ

OXLC

OXLCI

OXLCL

OXLCN

OXLCO

OXLCP

OXLCZ

STIP

TCANF

TCENF

TCEYF

TCNCF

TNCAF

TRIN

TRINI

TRINL

TRINZ

TRPPF

TRPRF

Press Releases

Oxford Lane Capital Corp. Schedules Fourth Fiscal Quarter Earnings Release and Conference Call for May 14, 2024

Oxford Lane Capital Corp. Announces Increase in Monthly Common Stock Distributions and Announces Net Asset Value and Selected Financial Results for the Fourth Fiscal Quarter

Oxford Lane Capital Corp. Provides April Net Asset Value Update

Oxford Lane Capital Corp. Provides May Net Asset Value Update

IPOs

Oxford Lane Capital Corp. Announces Offering of Notes

Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030

Oxford Lane Capital Corp. Schedules First Fiscal Quarter Earnings Release and Conference Call for July 26, 2024

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending October, November, and December 2024

Oxford Lane Capital Corp. Provides July Net Asset Value Update

Oxford Lane Capital Corp. Provides August Net Asset Value Update

OXLCM

Oxford Lane Capital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLC#NASDAQ">OXLC</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCM#NASDAQ">OXLCM</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCP#NASDAQ">OXLCP</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCL#NASDAQ">OXLCL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCO#NASDAQ">OXLCO</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCZ#NASDAQ">OXLCZ</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCN#NASDAQ">OXLCN</a>) (the &quot;Company&quot;) today announced that it has priced an underwritten public offering of&nbsp;$100,000,000&nbsp;in aggregate principal amount of&nbsp;8.75%&nbsp;unsecured notes due 2030. The notes will mature on June 30, 2030, and may be redeemed in whole or in part at any time or from time to time at the Company&#39;s option on or after June 30, 2028. The notes will bear interest at a rate of&nbsp;8.75%&nbsp;per year payable quarterly on March 31, June 30, September 30, and December 31 of each year, commencing September 30, 2024. 
&nbsp;

The offering is expected to close on July 8, 2024, subject to customary closing conditions. The Company has granted the underwriters an option to purchase up to an additional&nbsp;$15,000,000&nbsp;in aggregate principal amount of notes. The notes are expected to be listed on the NASDAQ Global Select Market and to trade thereon within 30 days of the original issue date under the trading symbol &quot;OXLCI&quot;.

The Company expects to use the net proceeds from this offering to acquire investments in accordance with its investment objective and strategies and for general working capital purposes.

Reported Earlier, Oxford Lane Capital Raises $100M Via Public Offering Of 8.75% Notes Due 2030 To Acquire Investments

Oxford Lane Capital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLC#NASDAQ">OXLC</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCM#NASDAQ">OXLCM</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCP#NASDAQ">OXLCP</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCL#NASDAQ">OXLCL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCO#NASDAQ">OXLCO</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCZ#NASDAQ">OXLCZ</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXLCN#NASDAQ">OXLCN</a>) (the "Company," "we," "us" or "our") today announced preliminary estimates and financial highlights as of and for the three months ended March 31, 2024, which are estimated as of April 17, 2024.&nbsp;<figure class="table"><table><tbody><tr><td>Preliminary Estimates (unaudited)</td><td>Estimated Ranges for the Three Months Ended March 31, 2024</td></tr><tr><td>Net investment income1</td><td>$0.20 - $0.24</td></tr><tr><td>Realized (losses)/gains1</td><td>$(0.03) - $0.01</td></tr><tr><td>Unrealized appreciation1</td><td>$0.06 - $0.10</td></tr><tr><td>Core net investment income1</td><td>$0.32 - $0.38</td></tr><tr><td>Net asset value</td><td>$4.85 - $4.95</td></tr><tr><td>Additional Details (unaudited)</td><td>Amounts as of March 31, 2024</td></tr><tr><td>Distributions per share paid on common stock during the quarter</td><td>$0.24</td></tr><tr><td>Common shares outstanding (approximately)</td><td>239.1 million</td></tr><tr><td>Number of portfolio investments</td><td>&nbsp;249</td></tr><tr><td>Total company preferred stock and debt outstanding</td><td>$487.2 million</td></tr><tr><td>Weighted average shares of common stock outstanding (approximately)</td><td>226.7 million</td></tr><tr><td>Cash and cash equivalents (approximately)</td><td>$43.0 million</td></tr><tr><td>1. Per share amounts based on weighted average shares outstanding for the quarter presented.</td><td>&nbsp;</td></tr></tbody></table></figure>The Company will release its fourth fiscal quarter 2024 operating results in May 2024.The preliminary financial data included in this press release&nbsp;has been prepared by, and is the responsibility of, the Company's&nbsp;Management.&nbsp;PricewaterhouseCoopers LLP has not audited, reviewed, compiled, or applied agreed-upon procedures with respect to the preliminary financial data.&nbsp;Accordingly, PricewaterhouseCoopers LLP does not express an opinion or any other form of assurance with respect thereto.Supplemental Information Regarding Core Net Investment Income&nbsp;EstimatesWe provide information relating to core net investment income ("NII") (a non-U.S. generally accepted accounting principles ("GAAP") measure) on a supplemental basis. This measure is not provided as a substitute for GAAP NII, but in addition to it. Our non-GAAP measures may differ from similar measures by other companies, even in the event of similar terms being utilized to identify such measures. Core NII represents GAAP NII adjusted for additional applicable cash distributions received, or entitled to be received (if any, in either case), on our CLO equity investments. The Company's management uses this information in its internal analysis of results and believes that this information may be informative in assessing the quality of the Company's financial performance, identifying trends in its results and providing meaningful period-to-period comparisons.Income from investments in the "equity" class securities of CLO vehicles, for GAAP purposes, is recorded using the effective interest method; this is based on an effective yield to the expected redemption utilizing estimated cash flows, at current cost, including those CLO equity investments that have not made their inaugural distribution for the relevant period end. The result is an effective yield for the investment in which the respective investment's cost basis is adjusted quarterly based on the difference between the actual cash received, or distributions entitled to be received, and the effective yield calculation.Furthermore, in order for the Company to continue qualifying as a regulated investment company for tax purposes, we are required, among other things, to distribute at least 90% of our investment company taxable income annually. While Core NII may provide a better indication of our estimated taxable income than GAAP NII during certain periods, we can offer no assurance that will be the case, however, as the ultimate tax character of our earnings cannot be determined until after tax returns are prepared at the close of a fiscal year. We note that this non-GAAP measure may not serve as a useful indicator of taxable earnings, particularly during periods of market disruption and volatility, and, as such, our taxable income may differ materially from our Core NII.The following table provides a reconciliation of GAAP NII to Core NII (using the mid-point of the preliminary estimate ranges) for three months ended March 31, 2024:<figure class="table"><table><tbody><tr><td>Preliminary Estimates for the Three Months Ended</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>March 31, 2024</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>(Per Share Amounts)</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>Net investment income2……………......……..</td><td>$</td><td>0.22</td></tr><tr><td>CLO equity adjustments……………….….......</td><td>$</td><td>0.13</td></tr><tr><td>Core net investment income1,2…………….....</td><td>$</td><td>0.35</td></tr></tbody></table></figure>1. See the information in this "Supplemental Information Regarding Core Net Investment Income Estimates" section above for more information.2. Based on the mid-point of the net investment income per share range disclosed above.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Oxford Lane Capital Corp. Preliminary Q4 Core Net Investment Income $0.32-$0.38; Cash And Cash Equivalents ~$43M

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Oxford Lane Capital

News

Latest news for Oxford Lane Capital (NASDAQ:OXLCN) Stock

Friday, June 28, 2024

Wednesday, April 17, 2024